Clinical trials to ameliorate hypoxia as a strategy to relieve the radiation resistance it causes have prompted a need to assay the precise extent and location of hypoxia in tumors. Electron paramagnetic resonance oxygen imaging (EPR O 2 imaging) provides a noninvasive means to address this need. To obtain a preclinical proof-ofprinciple that EPR O 2 images could predict radiation control, we treated mouse tumors at or near doses required to achieve 50% control (TCD 50 ). Mice with FSa fibrosarcoma or MCa4 carcinoma were subjected to EPR O 2 imaging and immediately radiated to a TCD 50 or TCD 50 AE 10 Gy. Statistical analysis was permitted by collection of approximately 1,300 tumor pO 2 image voxels, including the fraction of tumor voxels with pO 2 less than 10 mm Hg (HF10). Tumors were followed for 90 days (FSa) or 120 days (MCa4) to determine local control or failure. HF10 obtained from EPR images showed statistically significant differences between tumors that were controlled by the TCD 50 and those that were not controlled for both FSa and MCa4. Kaplan-Meier analysis of both types of tumors showed that approximately 90% of mildly hypoxic tumors were controlled (HF10%< 10%), and only 37% (FSA) and 23% (MCa4) tumors controlled if hypoxic. EPR pO 2 image voxel distributions in these approximately 0.5 mL tumors provide a prediction of radiation curability independent of radiation dose. These data confirm the significance of EPR pO 2 hypoxic fractions. The 90% control of low HF10 tumors argue that 0.5 mL subvolumes of tumors may be more sensitive to radiation and may need less radiation for high tumor control rates. Cancer Res; 73(17); 5328-35. Ó2013 AACR.
Introduction
It has been just over a century since Schwarz first observed the sensitizing effect of oxygen on tissue response to radiation (1) . This has led to many attempts to exploit modification of tumor hypoxia to enhance cancer control with radiation in humans. Among hypoxic modifiers, hyperbaric oxygen (2, 3) , carbogen, and radiation sensitizers (4) have been attempted in human trials with mixed, but suggestive results. Recently a meta-analysis of all hypoxic modifier studies in head and neck cancer has been conducted showing an improved tumor control and survival when any hypoxic modification is given in conjunction with curative radiotherapy, but, so far, a general application to the clinic has been limited (5, 6) .
These studies were attempted in patients with remarkably little feedback from patient and tumor-specific studies to determine the individual extent of hypoxia. An assumption of hypoxic universality was made. This was based on the lack of available methodology to distinguish tumors that were hypoxic, and that might have benefited from hypoxic intervention, from those that were well-oxygenated/mildly hypoxic and would not benefit from the intervention. Studies, like ref. 7 , have determined that the mean or median pO 2 in tumors, obtained with an invasive Eppendorf electrode can predict of success or failure of radiation treatment. Electron paramagnetic resonance (EPR) spectra from implanted particulate spin probe broaden in proportion to the local concentration of oxygen. This has allowed point sampling of local oxygen concentrations and shown its ability to predict radiation sensitivity (8) (9) (10) . The difficulty in quantification of pO 2 or hypoxia with radionuclide reductive retention assays has limited their use (11) . These measurements motivate the development of imaging techniques that can survey entire tumors and provide quantitative (and thereby reproducible) tumor oxygenation patterns and statistical summaries of those patterns. This would allow not only identification of whole tumor hypoxic fractions, but also identification of resistant tumor subregions that require increased radiation dose.
EPR oxygen images (EPR O 2 images) provide three-dimensional distributions of pO 2 in native, unperturbed conditions using injected nontoxic small-molecule pO 2 reporters of the environment (11) (12) (13) (14) (15) . Spectroscopic imaging allows direct interrogation of the highly specific and sensitive EPR spectral response of these reporter molecules with spatial resolution of approximately 1 mm and pO 2 resolution of 3 mm Hg (14) . We have shown previously that EPR O 2 images provide accurate tumor oxygenation information when compared with fluorescence OxyLite probe, both in terms of pO 2 values and their spatial distribution (15) in 0.5 mL FSa fibrosarcomas.
Our previous work in FSa fibrosarcomas radiated with a single dose in the range between 20 and 50 Gy showed that hypoxic fraction of voxels less than 10 mm Hg (HF10) obtained from EPR O 2 images strongly and independently correlated with tumor control (16) . Bivariate analysis of these irradiated tumors showed that they could be divided into failed and controlled populations based on both dose and the HF10. The sloped HF10 versus dose boundary line separating failed and controlled tumors allowed us to predict, more accurately, the dose increase necessary to control a given tumor.
Taking this a step further, we hypothesize that oxygenation information obtained from EPR O 2 images taken before the treatment will allow us to predict the response of an individual tumor to the single-dose radiation at the TCD 50 level, or a small range of doses near the TCD 50 . By the definition, TCD 50 radiation dose should lead to a local control of 50% of tumors. Hypoxic tumors treated with or near the TCD 50 dose would be predicted to more likely to recur, whereas mildly hypoxic tumors would be more likely be controlled. The goal of this study was to show that EPR O 2 images would predict which tumors will be controlled after treating with a TCD 50 radiation dose. To show the universality of this approach, we have included both FSa fibrosarcoma and MCa4 adenocarcinoma, differing in their radiosensitivity with TCD 50 s of 38 and 69 Gy, respectively.
Development of this approach toward the clinical use will enable dose painting. Identification of hypoxic subvolumes within a tumor using EPR O 2 images would allow adjusting the radiation treatment plan with modification of the dose according to the spatial localization of these subvolumes.
Materials and Methods

Animals and tumors
A total of 38 C3H/HeN:Hsd (Harlan Sprague-Dawley) female mice, 6 to 8 weeks old, were injected intramuscularly with 5 Â 10 5 FSa F9 generation fibrosarcoma cells (provided as F6 generation cells by Kathryn Mason, M.D. Anderson Cancer Center, Houston, TX) into the right hind leg. The tumors grew to 350 to 500 mL within 7 to 10 days. At the time of treatment, tumor volume was 488 AE 50 mL. The same procedure was used for MCa4 F6 tumors (M.D. Anderson Cancer Center) injected in the gastrocnemius of the right leg of C3H/HeN:Hs d mice. Tumors were treated at a volume of 312 AE 84 mL. The mice underwent first EPR imaging and then were immediately treated with radiotherapy, under the same level of isofluorane anesthesia (details below). Both cells lines underwent IMPACT1 PCR screening for murine pathogens at Missouri University's IDEXX RADIL diagnostic laboratories: (http://www.idexxbioresearch. com/radil/Health_Monitoring/Mouse_PCR_Profiles/index. html). No pathogens on the IMPACT1 list were found. For tumor injection, only material from F9 and F6 passaging generations were used. All animal experiments were carried out according to the USPHS "Policy on Humane Care and Use of Laboratory Animals" and the protocols were approved by the University of Chicago Institutional Animal Care and Use Committee (ACUP No. 69681). The University of Chicago Animal Resources Center is an Association for Assessment and Accreditation of Laboratory Animal Care-approved animal care facility.
Tumor control
The tumors were measured twice weekly. Local failure was declared when tumor reached twice its original volume according to three crossed diameter measurements. The tumors were deemed to have been controlled at 90 days after radiotherapy if the tumor did not fail. No FSa tumors controlled at 90 days showed any regrowth, much less that approaching twice its volume. MCa4 tumors did fail later than 90 days so that the time for assessment of MCa4 tumors was extended to 120 days. Because MCa4 failures were much slower, tumors showing slow regrowth after 90 days were sent for histologic analysis to determine the presence of tumor versus scar for legs treated to the higher doses necessary for tumor control.
Radiotherapy
Radiation doses were delivered in a single fraction given locally to the tumor, using 250 KVp X-rays from a Phillips RT 250 (Phillips) hardened with 0.5 mm Cu, giving a half-value layer of 1.9 mm Cu. The dose rate was approximately 3.5 Gy/min. This dose rate was achieved using a jig that rigidly attached to the RT 250 bringing the tumor center to 28 cm from the source. TCD 50 for FSa tumors in air-breathing animals was previously determined. Those measurements indicated a TCD 50 of 33.8 þ0.6/À0.2 Gy for animals breathing air, with no oxygenation manipulation, consistent with the published values (17) . MCa4 tumors were irradiated with a narrow range of doses, between 60-80 Gy, near the TCD 50 of 69 Gy reported in the literature (18) and measured by us. The tumors were immobilized for radiotherapy with a vinyl polysiloxane dental mold half circumference cast (GC America), which was used also for EPR imaging. Radiation dose was corrected for the effect for the cast. All other aspects of animal preparation for radiotherapy were identical to that for imaging.
Oxymetric spin probe
For each image of an FSa fibrosarcoma grown in a mouse leg, 20 mg/25 g mouse (0.8 g/kg, equivalent to 0.56 mmol/kg animal weight) of OX063 trityl(methyl-tris[8-carboxy-2, 2,6,6-tetrakis [1, 3] dithiol-4-yl] trisodium salt; molecular weight, 1,427; GE Healthcare, London, UK) was injected in 0.3 mL of deionized water (pH, 7.6; tonicity, 280 mOsm). Additionally, 13.1 mg of OXO63/25 g mouse/hour was infused via tail vein over the 30-minutes duration during which two 10-minute EPR oxygen images were obtained. This procedure allowed us to maintain approximately a constant level of oximetric spin probe in the tumor, as was monitored by the EPR signal. For MCa tumors, OX063 d24 trityl(methyl-tris[8carboxy-2, 2,6,6-tetrakis[(2-hydroxy-2d 2 -ethyl]benzo[1,2-d:4,5-d0]bis [1, 3] dithiol-4-yl] trisodium salt was used at the same concentrations used for native isotope abundance OX063.
Deuterated OX063 has a peak to peak linewidth of 8 mT, half that of native isotope abundance. This allowed the use of gradients of strength half of that for native abundance giving higher signal to noise ratio.
Anesthesia, immobilization, and preparation of mice
The mice were prepared for imaging as described by Elas and colleagues (16) . In brief, the mice inhaled sufficient isoflurane vapor (1-2%) to achieve normal breathing at 1-2 Hz and the absence of voluntary movement. Vinyl polysiloxane dental mold material, encompassing approximately one-half of the circumference of the leg, was used to immobilize the tumorbearing leg (Fig. 1 ). The anesthesia was begun 40 minutes before EPR imaging. The skin temperature was maintained at 33.5 C (corresponding to 37 C of animal rectal temperature) using opposed heating lamps and measured with a Physitemp digital thermometer, during all procedures.
EPR imaging
The general design of the 250 MHz pulse imager used in this study is described elsewhere (19) ; a new transmit/receive switch used here enabling 1 KW peak pulse power operation with a reflection resonator is described elsewhere (20) . RF power of 62.5 and 250W, respectively, was used to generate an ESE sequence with p/2 and p pulses with durations of 35 ns (19) . This used a fast, switched attenuator to produce the pulses of equal length and different tip angles. The influence of the system RF pulse frequency bandpass profile on image intensity was compensated as described in ref. 19 .
EPR O 2 imaging for FSa fibrosarcomas. FSa fibrosarcomas were imaged with ESE alone. We acquired five images with delays between the pulse pairs, t, logarithmically spaced in the range from 630 ns and 2.4 ms. For each image, we acquired 208 projections and 53 interleaved baselines for artifact suppression. For FSa fibrosarcoma imaging, the gradient amplitude was 15 mT/m; an equal solid angle scheme (21) was used for gradient directional spacing. For MCa4 tumors, O 2 imaging was accomplished with an extra inversion recovery pulse before the ESE image readout. The use of deuterated trityl allowed the gradient amplitude to be reduced to 7.5 mT/m.
The ESE data acquisition and processing methods are discussed in detail elsewhere (19) . Briefly, the transverse relaxation rate R 2 ¼ 1/gT 2 , where g is the electron gyromagnetic ratio, was evaluated by fitting the signal intensity in every voxel of the image to an exponential decay function of 2t. The fitted logarithmic slope of the function, R 2 , is a linear function of pO 2 . This slope is virtually independent of fluid viscosity so that aqueous calibration provides a reliable estimate of this slope. The extrapolation of the exponential decay function to t ¼ 0 provides an estimate of the EPR line shape integral. This integral can be related to the number of spins in a voxel in comparison with homogeneous solution image. The ESE T 2 image acquisition time was 10 minutes.
Assuming that the spin probe uniformly distributes in the voxel volume, the median spin probe concentration was 0.2 to 0.4 mmol/L in different tumors. However, the spin probe is a trianionic acid of molecular weight 1,427 D, excluded from intracellular distribution (22) . As the spin probe may not uniformly occupy the tissue volume, the local concentration may be underestimated by a factor of 2 to 5. On the basis of saline solution measurements of R 2 dependence on spin probe concentration, a general concentration correction of 30 mG/ mmol/L was applied, using regional amplitude concentration estimates of concentration to the pO 2 values, corresponding to a pO 2 shift of 6 to 12 mm Hg to all oxygen values for tumor pO 2 values. The correction corresponds to an estimated exclusion volume of 3.5. This empiric correction was applied to account for the spin probe self-relaxation or broadening effect.
EPR O 2 images for MCa4 carcinomas. EPR technique evolved and improved between experiments with FSa fibrosarcomas and MCa4 carcinomas. A pulse sequence was developed to reduce the need for concentration correction of relaxation rates to below measurement uncertainty (23) . Inversion recovery sequences to estimate voxel pO 2 values for MCa4 carcinomas avoid this concentration in correction. Data (not presented) indicated that in normal saline solutions, concentration relaxation of trityl spin probe was diminished by a factor of 5, rendering a correction unnecessary. Magnetization inversion was created using a 35 ns p applied at eight different time intervals T, referred to as inversion times, before a spin echo image readout with fixed t optimized for signal to noise to 700 ns, 200 ns more than the system dead time. Seven inversion times logarithmically spaced from 650 ns to 4 microseconds were used. An eighth ESE with no inversion pulse was used to simulate infinite recovery time and, for the purpose of fitting to an exponential inversion recovery, was assigned to the inversion time of 16 microseconds. Nonimaging measurements showed this to give relaxation rates no different than longer time assignments to within a 0.2 mm Hg equivalent relaxation rate uncertainty. No concentration correction was used for these voxel pO 2 estimates, and the IRESE T 1 image acquisition time was 10 minutes.
Location of tumor voxels in EPR image
Holes were molded in the vinyl polysiloxane cast that tightly accommodated two or three 1 mm inner diameter, 3 to 4 cm long borosilicate glass sample tubes containing either 10 mmol/L OX063 (EPR imaging) or water (MRI) as fiducial markers for coregistration of EPR imaging with MRI ( Fig. 1 ). Rapid acquisition with refocused echoes spin-echo images were acquired at 9.4 T on an Omega Bruker/GE imager with the following parameters: repetition time, 3,000 ms; effective excitation time, 56 ms; field of view, 3.0 cm; matrix size, 256 Â 256; slice thickness, 1 mm; NEX, 1; and rare factor, 8. The MRI with the water fiducials was registered with an image of the EPR fiducials. Registration of the EPR image and MRI images was done in several steps, using in-house software written in MATLAB, version 7.11 (Mathworks), allowing for human intervention. The initial registration estimate was done using an alignment of surfaces of the external fiducials. Next, a manual fine-matching of the tumor EPR image and MRI surfaces was conducted, going through all slices within the tumor volume in three directions. A slice of the EPR image with the MRI-defined tumor voxels is shown as the red contour in Fig. 2 .
Statistical analysis
Several tumor oxygenation characteristics were considered, including the median oxygen values of the tumor voxels and fraction of tumor voxels with less than 10 mm Hg oxygen tension (HF10). The fractions of tumor voxels less than these values were evaluated for each tumor. Significance of the comparison of tumors that failed radiation and those that were controlled was estimated via a Student two-tailed t test. P values <0.05 were considered significant. The significance of HF10 <10% as a predictor for failure for FSa fibrosarcomas and the HF < 10% or HF < 15% for the MCa4 tumors in the Kaplan-Meier survival curves was analyzed using Wilcoxon test. The analyses were conducted using the STATA, version 9, statistical package (StataCorp).
Results
Hypoxia visualized in EPR O 2 images
EPR oxygen images of MCa4 carcinoma tumor show severe hypoxia in the tumor in comparison with much better oxygenated normal leg areas, as seen from the example shown in Fig. 2 . Both histograms of the pO 2 values from the leg and from the tumor are skewed toward lower pO 2 values, with high number of voxels displaying near zero pO 2 . Median pO 2 in the tumor at 9 mm Hg was half of that in the whole leg.
For the tumor volume as defined from the MRI (red outline in Fig. 2) , several oxygenation statistics were determined from the EPR O 2 images including median pO 2 and fraction of the voxels with pO 2 less than 10 mm Hg. HF10 values determined from EPR O 2 images varied between tumors from 0% to 27% (FSa) and from 0% to 64% (MCa4). The oxygen images were acquired within 10 minutes, and oxygen partial pressure shown in the images is therefore averaged over this time.
Treatment with TCD 50 dose
The TCD 50 was determined using the procedure described by Suit and colleagues (24) as previously reported (16) . FSa fibrosarcoma tumors as uniform in size as possible, but differing in oxygenation, were treated with a single dose of 33.8 Gy. After 90 days, 37% of FSa tumors (14/38) regrew, whereas 63% (24/38) were controlled. MCa4 tumors of approximately the same size were treated with a range of 60 to 80 Gy, which is a narrow range around TCD 50 value of 69 Gy consistent with the literature (18) . This resulted in tumor growth inhibition and regression. In some cases, a regrowth occurred, but seemed to be slower than for FSa fibrosarcomas. In case of MCa4 tumors, at 120 days after treatment, 60% (24/40) regrew and 40% (16/40) were controlled. Another subset of MCa4 mice, distributed more tightly around the TCD 50 dose, i.e., animals treated with 66 to 72 Gy (69 AE 3 Gy) was also analyzed. Table 1 shows the mean of HF10 and median pO 2 from controlled and failed FSa and MCa4 tumors. HF10 significantly distinguishes failure from control in the two populations. This can also be clearly seen in Fig. 3 , showing Kaplan-Meier plots of the two populations of mice defined by the 10% threshold for the HF10. For 0.5 mL FSa tumors, those whose EPR O 2 images showed hypoxia, with HF10 more than 10%, 7 of 19 (36.8%) were controlled. For mildly hypoxic tumors, based on the EPR O 2 images with HF10 less than 10%, 17 of 19 (90%) were controlled. In case of MCa4 carcinoma, only 23% (7/30) of hypoxic tumors were controlled and 90% (9/10) of mildly hypoxic tumors with HF10 less than 10% were controlled at 120 days after therapy. In the smaller subset of MCa4 tumors treated with 66 to 72 Gy, with HF10 15% as a threshold value, 15% (3/20) of hypoxic tumors were controlled and 80% (4/5) of mildly hypoxic, i.e., with HF10 less than 15% were controlled at 120 days after therapy.
HF10 >10% was a significant predictor of tumor failure as determined by Wilcoxon analysis of survival data (P ¼ 0.0138 for FSa, and P ¼ 0.0072 for MCa4, for MCa4 subset HF10 > 15% P ¼ 0.0193). The mouse survival remarkably reflects that of patients with cervical cancer presented in Hockel and colleagues (25) with the time scale converted from days to months, reflecting, roughly, the factor of 30 difference in species' lifetimes. The threshold for the sampling in both measurements was 10 mm Hg and there is a rough doubling of survival probability in both subject sets for mildly hypoxic tumors versus hypoxic tumors.
Discussion
EPR O 2 images are a direct, quantitative, and noninvasive method of assessing tumor oxygenation (26) . pO 2 statistics determined from tumor images predicts the tumor response to a single dose of radiation. Hypoxic fraction of less than 10 mm Hg at the level of 10% divided tumors controlled after therapy from those that failed the therapy as seen dramatically in Fig. 3 . It is clear that the mildly hypoxic tumors with HF10 less than 10% are controlled with 90% probability. For hypoxic tumors, defined here as having an HF10 more than 10%, the control probability decreases dramatically to less than 37% for FSa tumors and to 23% for MCa4 tumors. However, as indicated from the statistical analysis, the 90% versus 37% control argue that the populations separated by HF10 are significantly different. It is tempting to observe that for tumors with HF10 less than 10%, the TCD 50 is a TCD 90 . It suggests that regions of tumors may be highly hypoxic and require higher radiation doses and that regions that are relatively well-oxygenated or mildly hypoxic may require less radiation for equivalent control. If such images were available for human use, EPR O 2 images could be used for dose painting (27) (28) (29) .
Both FSa and MCa4 tumor models are well-characterized radiobiologically (16) (17) (18) . Instead of a fixed TCD 50 dose, as we used for FSA tumors, for MCa4, we used the dose interval of AE 10 Gy around their TCD 50 . These data were obtained from our own measurement of the MCa4 tumor TCD 50 . Our reason was to provide early indication that the hypoxic fraction might be useful in this second tumor type in predicting tumor response to radiation. Moreover, with varying dose, one might expect that the effect of the HF10 on tumor control would be weakened. In contrast, our results show high statistical significance of HF10 in predicting tumor control. The analysis of the smaller subset of animals, treated with 66-72 Gy, confirmed our conclusions.
The specific choice of 10 mm Hg as the definition of voxel hypoxic fraction is based on earlier radiobiologic studies. In oxygen electrode measurements in human tumors, median pO 2 at the level of 10 mm Hg has been used to distinguish lymph nodes or tumors that responded to therapy from those that did not respond (7, 30, 31) .
What is more, the cellular response to hypoxia, i.e., the HIF system, was induced at half maximal level at 10 to 15 mm Hg (32) . In tumors, pO 2 of approximately 10 mm Hg represents a critical threshold for energy metabolism (33) .
The higher significance of the HF10 relative to lower threshold pO 2 values in our measurements (data not shown) likely derives from the larger number of voxels with pO 2 less than 10 mm Hg relative to the number of voxels in samples obtained with lower thresholds. Interestingly, the 10 mm Hg threshold produces a Kaplan-Meier survival curve in both fibrosarcomas and adenocarcinomas familiar from human tumor measurements provided by invasive microelectrode measurements. The significance of the survival difference seen in Fig. 3 is quite high, as noted above.
In our previous work with FSa fibrosarcoma irradiated with varied radiation doses from 20 to 50 Gy, we analyzed the effect images on the results of the treatment. A range of pO 2 thresholds was used to define the hypoxic fraction. Statistics that characterized the entire tumor such as mean and median pO 2 in the tumor showed a much weaker association with tumor control. Analysis with mean and median pO 2 as the tumor statistic gave substantially lower pseudo-R2 correlation on bivariate logistical analysis. They also showed increased misclassification rates. However, given the large gradients and pO 2 variations in the image, as in Fig. 2 , such overall descriptors of the oxygenation are not expected to show good correlation with tumor control. Interestingly, median pO 2 was highly significant for the MCa4 tumor. EPR spectroscopic oximetry has been used previously to predict sensitivity to radiation in multiple experimental settings (10, 34) . This method has proven to be useful to identify possible areas of resistance during modulations of tumor hypoxia using drugs and antiangiogenic treatments (35) (36) (37) (38) . EPR oximetric imaging, however, provides quantitative infor-mation on oxygenation and hypoxia from the whole imaged volume, and is therefore a more thorough tool to identify the hypoxic fractions within the tumors to improve the therapy outcome (23, 39) .
Concern may be raised about the applicability of these data to patient treatment. This work involved administration of a single large fraction of radiation to the animal model tumor. Most therapeutic regimens delivered today involve highly fractionated regimens (40) . During such administration, oxygenation patterns are likely to change (41, 42) . In this context, the work presented here can be presented as an argument for more frequent O 2 images. Alternatively, it argues that further investigation into the temporal changes in the spatial distributions of hypoxic regions need to be considered.
Conclusions
One of the major values of knowing the distribution of oxygen tensions in an animal tumor is the insight that (17/19) with HF10 less than 10% were controlled at 90 days after treatment. In contrast, only 37% of tumors (7/19) were controlled at 90 days when their HF10 was higher than 10%. B, MCa4 tumors were treated with a single dose in the range of 60-80 Gy. Ninety percent of tumors (9/10) with HF10 < 10% were controlled at 120 days after treatment, whereas 23% (7/30) with HF10!10% were controlled at 120 days. Wilcoxon test shows that HF10 > 10% threshold was a significant predictor of tumor failure (P ¼ 0.0138 for FSa, and P ¼ 0.0072 for MCa4 tumors). C, subset of MCa4 tumors treated with a single dose in the range of 66-72 Gy. Eighty percent of tumors (4/5) with HF10 15% were controlled at 120 days after treatment, whereas 15% (3/20) with HF10 >15% were controlled at 120 days. Wilcoxon test shows that HF10 >15% threshold was a significant predictor of tumor failure (P ¼ 0.0193).
it gives into the distribution of radiation doses that should be administered to optimally treat a tumor. The current practice of maintaining dose homogeneity over a tumor volume is a statement of ignorance as to the spatial variation of radiation sensitivity within the tumor. We have shown that for two tumor types, mildly hypoxic 0.5 mL tumors treated to a nominal TCD 50 , 90% were controlled, whereas only 37% and 23% of more poorly oxygenated tumors were controlled. In future, the quantitative, noninvasive EPR O 2 images of human tumors and local oxygenation statistics like HF10 from subvolumes within the tumor might allow targeting a local dose modification to improve local control.
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